The Evolving Role of Liquid Biopsies

David R. Gandara, MD, FASCO, discusses the evolving role of liquid biopsy in therapeutic decision-making for Non-small Cell Lung Cancer (NSCLC).

Back to Symposium Page »


February 20, 2021

Created by

Scripps CME Connection

Related Presenters

David Gandara, MD, FASCO

David Gandara, MD, FASCO

Professor of Medicine Emeritus
Director, Thoracic Oncology Program
University of California Davis Comprehensive Cancer

Dr. Gandara's research interests focus on developmental therapeutics of new anti-cancer agents as well as preclinical modeling and clinical research in lung cancer.

View full profile